TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -1 | -7 | -12 | -15 | -3 | 4 | -6 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 0 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/4/16 17:19 | 5/2/16 | CEMI | Chembio Diagnostics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Larkin Richard J | NY | O | CFO | M.d | 101 | 4.35 | 0 | 23 | 80 | 52 | D | 133 | 54 | 48 | 46 | 27 | 13 | 1 | 1 | 1 | 1 | 21 | 2 | -5 | |
2/28/14 09:24 | 2/26/14 | CEMI | Chembio Diagnostics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Larkin Richard J | NY | O | CFO | S | -35 | 3.50 | 0 | -10 | -33 | 20 | D | -4 | -32 | 2 | 9 | 5 | 12 | 15 | 9 | -1 | -7 | -12 | -15 | -3 | 4 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |